Nontuberculous Mycobacteria: So-called atypical species of the genus MYCOBACTERIUM that do not cause tuberculosis. They are also called tuberculoid bacilli, i.e.: M. buruli, M. chelonae, M. duvalii, M. flavescens, M. fortuitum, M. gilvum, M. gordonae, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. kansasii, M. marinum, M. obuense, M. scrofulaceum, M. szulgai, M. terrae, M. ulcerans, M. xenopi.Mycobacterium Infections, Nontuberculous: Infections with nontuberculous mycobacteria (atypical mycobacteria): M. kansasii, M. marinum, M. scrofulaceum, M. flavescens, M. gordonae, M. obuense, M. gilvum, M. duvali, M. szulgai, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. xenopi (littorale), M. ulcerans, M. buruli, M. terrae, M. fortuitum (minetti, giae), M. chelonae.Mycobacterium Infections: Infections with bacteria of the genus MYCOBACTERIUM.Mycobacterium kansasii: A slow-growing, photochromogenic species that is the etiologic agent of a tuberculosis-like disease in humans and is frequently isolated from human pulmonary secretions or tubercles. The incidence of infection is sharply increased among immunocompromised individuals. (Dorland, 28th ed)Mycobacterium: A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts.Lung Diseases: Pathological processes involving any part of the LUNG.Mycobacterium tuberculosis: A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.Mycobacterium chelonae: A species of gram-positive, aerobic bacteria commonly found in soil and occasionally isolated from sputum. It causes postoperative wound infections as well as gluteal abscesses.Mycobacterium avium Complex: A complex that includes several strains of M. avium. M. intracellulare is not easily distinguished from M. avium and therefore is included in the complex. These organisms are most frequently found in pulmonary secretions from persons with a tuberculous-like mycobacteriosis. Strains of this complex have also been associated with childhood lymphadenitis and AIDS; M. avium alone causes tuberculosis in a variety of birds and other animals, including pigs.Mycobacterium fortuitum: A rapid-growing, nonphotochromogenic species that is potentially pathogenic, producing lesions of lung, bone, or soft tissue following trauma. It has been found in soil and in injection sites of humans, cattle, and cold-blooded animals. (Dorland, 28th ed)Mycobacterium avium-intracellulare Infection: A nontuberculous infection when occurring in humans. It is characterized by pulmonary disease, lymphadenitis in children, and systemic disease in AIDS patients. Mycobacterium avium-intracellulare infection of birds and swine results in tuberculosis.Mycobacterium marinum: A moderate-growing, photochromogenic species found in aquariums, diseased fish, and swimming pools. It is the cause of cutaneous lesions and granulomas (swimming pool granuloma) in humans. (Dorland, 28th ed)Lymphadenitis: Inflammation of the lymph nodes.Mycobacterium xenopi: A slow-growing, scotochromogenic species occurring usually harmlessly in human secretions but occasionally associated with chronic pulmonary disease. (Dorland, 28th ed)Mycobacterium avium: A bacterium causing tuberculosis in domestic fowl and other birds. In pigs, it may cause localized and sometimes disseminated disease. The organism occurs occasionally in sheep and cattle. It should be distinguished from the M. avium complex, which infects primarily humans.Mycobacterium scrofulaceum: A non-tuberculous mycobacterium causing cervical lymphadenitis in children. It very rarely causes pulmonary disease, and is believed to be non-pathogenic in animals.Sputum: Material coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus.Mycobacterium bovis: The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis.Tuberculosis, Pulmonary: MYCOBACTERIUM infections of the lung.Mycobacterium haemophilum: A species of gram-positive, aerobic bacteria that causes granulomatous or ulcerating skin lesions in immunosuppressed persons. This organism owes its name to its requirement for growth of high levels of iron, conveniently supplied as blood, heme, or ferric ammonium citrate.Tuberculosis: Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM.Skin Diseases, Bacterial: Skin diseases caused by bacteria.Mycobacterium smegmatis: A rapid-growing, nonphotochromogenic species of MYCOBACTERIUM originally isolated from human smegma and found also in soil and water. (From Dorland, 28th ed)Drinking Water: Water that is intended to be ingested.Bacteriological Techniques: Techniques used in studying bacteria.Nucleic Acid Probes: Nucleic acid which complements a specific mRNA or DNA molecule, or fragment thereof; used for hybridization studies in order to identify microorganisms and for genetic studies.DNA, Bacterial: Deoxyribonucleic acid that makes up the genetic material of bacteria.Chaperonin 60: A group I chaperonin protein that forms the barrel-like structure of the chaperonin complex. It is an oligomeric protein with a distinctive structure of fourteen subunits, arranged in two rings of seven subunits each. The protein was originally studied in BACTERIA where it is commonly referred to as GroEL protein.Antitubercular Agents: Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.Mycobacterium leprae: A species of gram-positive, aerobic bacteria that causes LEPROSY in man. Its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side.Water Microbiology: The presence of bacteria, viruses, and fungi in water. This term is not restricted to pathogenic organisms.Polymerase Chain Reaction: In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.RNA, Ribosomal, 16S: Constituent of 30S subunit prokaryotic ribosomes containing 1600 nucleotides and 21 proteins. 16S rRNA is involved in initiation of polypeptide synthesis.Bacterial Proteins: Proteins found in any species of bacterium.Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)Tuberculin Test: One of several skin tests to determine past or present tuberculosis infection. A purified protein derivative of the tubercle bacilli, called tuberculin, is introduced into the skin by scratch, puncture, or interdermal injection.Immunocompetence: The ability of lymphoid cells to mount a humoral or cellular immune response when challenged by antigen.Clarithromycin: A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit PROTEIN SYNTHESIS in BACTERIA by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation.Antigens, Bacterial: Substances elaborated by bacteria that have antigenic activity.Culture Media: Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN.Molecular Diagnostic Techniques: MOLECULAR BIOLOGY techniques used in the diagnosis of disease.Polymorphism, Restriction Fragment Length: Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment.Mycobacterium avium subsp. paratuberculosis: A subspecies of gram-positive, aerobic bacteria. It is the etiologic agent of Johne's disease (PARATUBERCULOSIS), a chronic GASTROENTERITIS in RUMINANTS.Bacterial Typing Techniques: Procedures for identifying types and strains of bacteria. The most frequently employed typing systems are BACTERIOPHAGE TYPING and SEROTYPING as well as bacteriocin typing and biotyping.Sequence Analysis, DNA: A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis.Water Supply: Means or process of supplying water (as for a community) usually including reservoirs, tunnels, and pipelines and often the watershed from which the water is ultimately drawn. (Webster, 3d ed)Anti-Bacterial Agents: Substances that reduce the growth or reproduction of BACTERIA.Species Specificity: The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species.Microbial Sensitivity Tests: Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).Immunocompromised Host: A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.Reagent Kits, Diagnostic: Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use.Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.Mycobacterium ulcerans: A slow-growing mycobacterium that infects the skin and subcutaneous tissues, giving rise to indolent BURULI ULCER.Mycobacterium phlei: A saprophytic bacterium widely distributed in soil and dust and on plants.Molecular Sequence Data: Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.Ethambutol: An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863)DNA, Ribosomal: DNA sequences encoding RIBOSOMAL RNA and the segments of DNA separating the individual ribosomal RNA genes, referred to as RIBOSOMAL SPACER DNA.Isoniazid: Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.Clofazimine: A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619)BCG Vaccine: An active immunizing agent and a viable avirulent attenuated strain of Mycobacterium tuberculosis, var. bovis, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity.Mycolic AcidsRifampin: A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160)Tuberculosis, Lymph Node: Infection of the lymph nodes by tuberculosis. Tuberculous infection of the cervical lymph nodes is scrofula.Bronchiectasis: Persistent abnormal dilatation of the bronchi.Prevalence: The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.Base Sequence: The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.Baths: The immersion or washing of the body or any of its parts in water or other medium for cleansing or medical treatment. It includes bathing for personal hygiene as well as for medical purposes with the addition of therapeutic agents, such as alkalines, antiseptics, oil, etc.Mycobacterium lepraemurium: The etiologic agent of rat leprosy, also known as murine leprosy.Rifabutin: A broad-spectrum antibiotic that is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients.
... the causative agent of whooping cough and nontuberculous mycobacteria. Aspiration of ammonia and other toxic gases, pulmonary ... Updated: Oct 13, 2015 Miller, JC (2006). "Pulmonary Mycobacterium Avium-Intracellular Infections in Women". Radiology Rounds. 4 ... "Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics". European Respiratory Journal. 28 (5): ... It is classified as an obstructive lung disease, along with chronic obstructive pulmonary disease and asthma. The diagnosis is ...
... (NTM) are all the other mycobacteria which can cause pulmonary disease resembling tuberculosis, ... Nontuberculous mycobacteria (NTM), also known as environmental mycobacteria, atypical mycobacteria and mycobacteria other than ... pulmonary infections are most commonly due to Mycobacterium avium complex (MAC), Mycobacterium kansasii, and Mycobacterium ... Pulmonary NTM disease diagnosis requires both identification of the mycobacterium in the patient's lung(s) as well as a high ...
Nontuberculous mycobacteria (NTM) are all the other mycobacteria, which can cause pulmonary disease resembling tuberculosis, ... 2013 A Systems Level Comparison of Mycobacterium tuberculosis, Mycobacterium leprae and Mycobacterium smegmatis Based on ... Structures of Mycobacterium tuberculosis proteins MycDB: Mycobacterium database TBDB: Tuberculosis database Mycobacterium ... Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria. American Thoracic Society. Am J Respiratory and ...
Johnson & Odell (2014); Nontuberculous mycobacterial pulmonary infections. J Thorac Dis.; 6(3): 210-220. PMCID: 3949190 Linmans ... Mycobacterium abscessus complex (MABSC) is a group of rapidly growing, multidrug-resistant non-tuberculous mycobacteria (NTM) ... 1992). "Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus ( ... "Pulmonary Nontuberculous Mycobacterial Disease, Ontario, Canada, 1998-2010". Emerging Infectious Diseases. 19 (11). doi:10.3201 ...
... is a nontuberculous species of the phylum actinobacteria (Gram-positive bacteria with high guanine and ... Pulmonary infections of M. fortuitum are uncommon, but Mycobacterium fortuitum can cause local skin disease, osteomyelitis ( ... Mycobacterium fortuitum is one of the many species of nontuberculosis mycobacteria (NTM) that are commonly found in the ... Bacteria classified as Mycobacteria, include the causative agents for tuberculosis and leprosy. Mycobacteria are sometimes ...
... one with nontuberculous mycobacteria or NTM, caused by Mycobacterium avium complex ("MAC"), which is made of three mycobacteria ... Reich JM, Johnson RE (June 1992). "Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle ... The Mycobacterium avium complex (MAC) includes common atypical bacteria, i.e. nontuberculous mycobacteria (NTM), found in the ... Mycobacterium avium complex is the most commonly found form of non-tuberculous mycobacteria. Immunodeficiency is not a ...
Girón RM, Domingo D, Buendía B, Antón E, Ruiz-Velasco LM, Ancochea J (October 2005). "Nontuberculous mycobacteria in patients ... March 2010). "Cystic Fibrosis Pulmonary Guidelines: Pulmonary Complications: Hemoptysis and Pneumthorax". Am J Respir Crit Care ... Pulmonary rehabilitation as a management of CF continues throughout a person's life, and is aimed at maximizing organ function ... It is not known if this type of therapy has an impact on pulmonary exacerbations or disease progression. It is not known what ...
"British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)". Thorax. 72 ... Mycobacterium avium complex is a group of mycobacteria comprising Mycobacterium intracellulare and Mycobacterium avium that are ... is part of the group of nontuberculous mycobacteria. These bacteria cause disease in humans called Mycobacterium avium- ... Pathogenic mycobacteria. Advances in Tuberculosis Research, 14, 235-287. *^ "Mycobacterium Avium Complex. MAI; MAC Information" ...
... according to the Runyon classification of Non-Tuberculous Mycobacteria. If grown in a lighted incubator, most strains form dark ... Chronic human pulmonary disease resembling tuberculosis (involvement of the upper lobe). Extrapulmonary infections, (cervical ... Mycobacterium kansasii is a bacterium in the Mycobacterium family. The genus includes species known to cause serious diseases ... ISBN 0-7216-2921-0. "Mycobacterium kansasii". NCBI Taxonomy Browser. 1768. Type strain of Mycobacterium kansasii at BacDive - ...
... this group in turn is part of the group of nontuberculous mycobacteria. These bacteria cause disease in humans called ... MAC infection can cause chronic pulmonary disease, lymphadenitis, and can cause disseminated disease, especially in people with ... Mycobacterium avium complex is a group of mycobacteria comprising Mycobacterium intracellulare, Mycobacterium avium, and ... Type strain of Mycobacterium intracellulare at BacDive - the Bacterial Diversity Metadatabase Type strain of Mycobacterium ...
On these bases, the nontuberculous mycobacteria are divided into four groups: The first three groups are classified as "Slowly ... Runyon EH (January 1959). "Anonymous mycobacteria in pulmonary disease". The Medical clinics of North America. 43 (1): 273-90. ... Mycobacterium fortuitum, Mycobacterium peregrinum, Mycobacterium abscessus, Mycobacterium chelonae, Mycobacterium ... The group includes Mycobacterium kansasii, Mycobacterium marinum, Mycobacterium asiaticum, and Mycobacterium simiae. ...
Interference by nontuberculous mycobacteria: Exposure to environmental mycobacteria (especially M. avium, M. marinum and M. ... BCG is very efficacious against tuberculous meningitis in the pediatric age group, but its efficacy against pulmonary ... and Robert Koch first distinguished Mycobacterium bovis from Mycobacterium tuberculosis. Following the success of vaccination ... In this study, the UK school children had a low baseline cellular immunity to mycobacteria which was increased by BCG; in ...
Because these antigens are only present in few non-tuberculous mycobacteria or not in any BCG vaccine strain, these tests are ... In active pulmonary TB, infiltrates or consolidations and/or cavities are often seen in the upper lungs with or without ... Other mycobacteria are also acid-fast. If the smear is positive, PCR or gene probe tests can distinguish M. tuberculosis from ... However, chest radiographs may be used to rule out the possibility of pulmonary TB in a person who has a positive reaction to ...
Mycobacterium tuberculosis: a once genetically intractable organism. In Molecular Genetics of the Mycobacteria, ed. GF Hatfull ... Cater, J. C.; Redmond, W. B. (1963). "Mycobacterial phages isolated from stool specimens of patients with pulmonary disease". ... MANKIEWICZ, E. (1961). "Mycobacteriophages isolated from Persons with Tuberculous and Non-tuberculous Conditions". Nature. 191 ... While originally isolated from the bacterial species Mycobacterium smegmatis and Mycobacterium tuberculosis, the causative ...
"Molecular Detection and Identification of Mycobacterium tuberculosis Complex and Four Clinically Important Nontuberculous ... Cudahy, Patrick; Shenoi, Sheela V. (2016-04-01). "Diagnostics for pulmonary tuberculosis". Postgraduate Medical Journal. 92 ( ... Mycobacterium tuberculosis is an obligate pathogenic bacterial species in the family Mycobacteriaceae and the causative agent ... ISBN 0-83-858529-9. Fu, L. M.; Fu-Liu, C. S. (2002-01-01). "Is Mycobacterium tuberculosis a closer relative to Gram-positive or ...
Mycobacterium kansasii）。後兩者被歸為非结核性分枝杆菌(NTM)（英语：Nontuberculous mycobacteria）。非结核性分枝杆菌既不能引起結核病也不能引起痲瘋病，但其感染會導致相似於結核病的肺部疾病。 ... Genetic Biodiversity of Mycobacterium tuberculosis Complex Strains from Patients with Pulmonary Tuberculosis in Cameroon. ... 结核分枝杆菌复合群(MTBC)包括其
Niobe-Eyangoh SN (2003.). "Genetic Biodiversity of Mycobacterium tuberculosis Complex Strains from Patients with Pulmonary ... American Thoracic Society (1997.). "Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official ... Skupina M. tuberculosis (MTBC) obuhvaća još četiri mikobakterije: Mycobacterium bovis, Mycobacterium africanum, Mycobacterium ... Druge patogene mikobakterije su Mycobacterium leprae, Mycobacterium avium, i Mycobacterium kansasii. Posljednje dvije se ...
American Thoracic Society (1997). "Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official ... 2003). "Genetic Biodiversity of Mycobacterium tuberculosis Complex Strains from Patients with Pulmonary Tuberculosis in ... "Pulmonary tuberculosis due to Mycobacterium microti: a study of six recent cases in France.". Journal of medical microbiology ... Textbook of pulmonary and critical care medicine. New Delhi: Jaypee Brothers Medical Publishers. s. 549. ISBN 978-93-5025-073-0 ...
American Thoracic Society (1997). "Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official ... "Pulmonary tuberculosis due to Mycobacterium microti: a study of six recent cases in France.". Journal of medical microbiology. ... Skupina M. tuberculosis (MTBC) obuhvaća još četiri mikobakterije: Mycobacterium bovis, Mycobacterium africanum, Mycobacterium ... Druge patogene mikobakterije su Mycobacterium leprae, Mycobacterium avium, i Mycobacterium kansasii. Posljednje dvije se ...
Panteix, G (2010 Aug). "Pulmonary tuberculosis due to Mycobacterium microti: a study of six recent cases in France". Journal of ... American Thoracic Society (1997). "Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official ... "Genetic Biodiversity of Mycobacterium tuberculosis Complex Strains from Patients with Pulmonary Tuberculosis in Cameroon". J. ... Textbook of pulmonary and critical care medicine. New Delhi: Jaypee Brothers Medical Publishers. hlm. 549. ISBN 978-93-5025-073 ...
... immune reactivity to nontuberculous mycobacteria (NTM), and a prior positive TST. In addition to the multicenter study, two ... Pulmonary Medicine. 2012: 1-7. doi:10.1155/2012/291294. Behrman, A; Buchta, WG; Budnick, LD; Hodgson, MJ; Raymond, LW; Russi, M ... False positive results can occur with Mycobacterium szulgai, Mycobacterium kansasii, and Mycobacterium marinum. On 10/10/2007 ... but can also be caused by infection with non-tuberculous mycobacteria. A negative IGRA does not rule out active TB disease; a ...
Griffith AS and Munro WT (1944). "Human pulmonary tuberculosis of bovine origin in Great Britain". J Hyg. 43 (4): 229-40. doi: ... Mycobacteria (including Nontuberculous). Slowly growing. (R1P=photochromogenic;. R2S=scotochromogenic;. R3N=nonchromogenic). ... Mycobacterium bovis. Karlson & Lessel 1970, ATCC 19210. Mycobacterium bovis (M. bovis) is a slow-growing (16- to 20-hour ... Mycobacterium bovis can be transmitted from human to human; there was an outbreak in Birmingham, England in 2004, and from ...
Diagnosis and treatment of disease caused by nontuberculous mycobacteria. American Journal of Respiratory and Critical Care ... Genetic biodiversity of Mycobacterium tuberculosis complex strains from persons with pulmonary tuberculosis in Cameroon. ... Dalšími známými zástupci z rodu Mycobacterium jsou M. leprae, komplex Mycobacterium avium a M. kansasii. Poslední dvě zmíněné ... Podrobnější informace naleznete v článku Mycobacterium tuberculosis.. Hlavním původcem tuberkulózy, Mycobacterium tuberculosis ...
2005). "Tuberculosis, nontuberculous lung infection, pleural disorders, pulmonary function, respiratory muscles, occupational ... and TB Prevention Nontuberculous mycobacteria Overcrowding Philip D'Arcy Hart Tuberculosis in history and art UNITAID ... other diseases caused by mycobacteria Latent tuberculosis List of tuberculosis victims Mycobacterium Tuberculosis Structural ... 3]. Around 80% of all TB cases are related to pulmonary or lung. Common symptoms include: coughing that lasts longer than 3 ...
Patients may also develop pulmonary alveolar proteinosis without mutations in the granulocyte-macrophage colony-stimulating ... This syndrome is characterized by an increased susceptibility to disseminated nontuberculous mycobacterial infections, viral ... "Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia ... pulmonary alveolar proteinosis and myeloid leukemias. Multiple mutations in the GATA2 are considered to be responsible for this ...
"Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic ... "Genetic biodiversity of Mycobacterium tuberculosis complex strains from patients with pulmonary tuberculosis in Cameroon". J. ... மைக்கோபாக்டீரியம் கனெட்டி (Mycobacterium canetti),. *மைக்கோபாக்டீரியம் மைக்குரோட்டி (Mycobacterium microti) முதலான ... Mycobacterium leprae தொழுநோயை உருவாக்கும் வல்லமை கொண்டது. Mycobacterium avium, M. kansasii ஆகிய இரண்டும் காசநோயை உருவாக்காத ...
M xenopi, a slow-growing, nontuberculous mycobacterium, is often considered to be a saprophyte or an environmental contaminant. ... Researchers first described Mycobacterium xenopi in 1959 after isolating it from skin lesions of the South African toad Xenopus ... Review of pulmonary Mycobacterium xenopi infection cases: 11 cases of our own and 18 other cases reported in Japan]. Kekkaku. ... Mycobacterium xenopi, Mycobacterium fortuitum, Mycobacterium kansasii, and other nontuberculous mycobacteria in an area of ...
Mycobacterium haemophilum is a slowly growing acid-fast bacillus (AFB) belonging to the group of nontuberculous mycobacteria ( ... Disseminated and pulmonary infections occasionally occur. The second at-risk group is otherwise healthy children, who typically ... Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections. Journal. Clinical microbiology ... mycobacterium-specific fragment with subsequent sequencing to identify M. haemophilum. No standard treatment guidelines are ...
Mycobacterium fortuitum is a nontuberculous species of the phylum actinobacteria (Gram-positive bacteria with high guanine and ... Pulmonary infections of M. fortuitum are uncommon, but Mycobacterium fortuitum can cause local skin disease, osteomyelitis ( ... Mycobacterium fortuitum is one of the many species of nontuberculosis mycobacteria (NTM) that are commonly found in the ... Bacteria classified as Mycobacteria, include the causative agents for tuberculosis and leprosy. Mycobacteria are sometimes ...
The Incidence of Nontuberculous Mycobacterial Pulmonary Infection in Bilateral Bronchiectasis and Bronchiolitis. Unknown status ... it belongs to a group of bacteria, known as nontuberculous mycobacterium, as it is different from the mycobacterium that causes ... Wikipedia : 71 Mycobacterium fortuitum is a nontuberculous species of the phylum actinobacteria (Gram-positive bacteria... more ... Pulmonary Mycobacterium fortuitum infection with cervical lymphadenitis in a patient carrying autoantibodies to interferon-I ...
Prevalence and Characteristics of Patients With Bronchiectasis Comorbid Nontuberculous Mycobacteria Aetiology of Children With ... Pulmonary Rehabilitation in Non Cystic Fibrosis Bronchiectasis Therapy of Bronchoalveolar Lavage and Local Amikacin Injection ... Current cigarette smoking - Active allergic bronchopulmonary aspergillosis - Diagnosis of tuberculosis or active non-tuberculous ... Pulmonary Rehabilitation in Non-Cystic Fibrosis Bronchiectasis Metabolomic Analysis of Exhaled Breath Condensates in Patients ...
Update on pulmonary disease due to non-tuberculous mycobacteria.. Stout JE1, Koh WJ2, Yew WW3. ... Non-tuberculous mycobacteria (NTM) are emerging worldwide as significant causes of chronic pulmonary infection, posing a number ... Mycobacterium abscessus), others (e.g., Mycobacterium malmoense, Mycobacterium xenopi) are regionally important. Thoracic ... Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University ...
NTM increases were driven exclusively by pulmonary isolates and disease. ... from pulmonary sites comprised 96% of species/patient combinations isolated; annual rates of isolation and cases increased ... Nontuberculous mycobacteria (NTM) cause pulmonary and nonpulmonary disease, but most isolates and disease cases are pulmonary ( ... Prevalence of pulmonary and nonpulmonary nontuberculous mycobacteria (NTM) isolation and pulmonary NTM disease in Ontario, ...
We report a case of pulmonary infection caused by Mycobacterium hassiacum in an immunocompetent patient in Austria who had ... chronic obstructive pulmonary disease. Antimicrobial drug susceptibility testing showed low MICs for macrolides, ... The clinical relevance of newly described nontuberculous mycobacteria is often unclear. ... Nontuberculous Mycobacterial Pulmonary Disease from Mycobacterium hassiacum, Austria On This Page Research Letter Cite This ...
Mycobacterium abscessus, Mycobacterium avium, Non-tuberculous mycobacteria, Pulmonary disease. Resource Type CF Research News ...
Mycobacterium intracellulare in two patients, Mycobacterium avium + Mycobacterium kansasii in one, Mycobacterium intracellulare ... Mycobacterium chelonae in one, Mycobacterium intracellulare + Mycobacterium abscessus in one, and Mycobacterium intracellulare ... Six patients (3.8%) were coincidental pulmonary infection due to two Mycobacterium species. We investigated the background, ... Although most patients were elderly with underlying disease and clinical features were compatible with pulmonary Mycobacterium ...
M. abscessus-chelonae group (1010, 49.9%) was the most commonly isolated and implicated in pulmonary NTM disease. Pulmonary ... Pulmonary NTM infection has the highest frequency with male and female patients associated with a higher incidence of COPD and ... Male patients were older (68.5 years, P = 0.014) with a higher incidence of chronic obstructive pulmonary disease (COPD) (23.6 ... This study aimed to delineate epidemiological and clinical features of pulmonary NTM disease. A retrospective review was ...
Here we report the incidence of NTM isolation in EW&NI between 2007 and 2012 from both pulmonary and extra-pulmonary samples ... were pulmonary, in whom incidence increased from 4.0/100,000 to 6.1/100,000 (p < 0.001). In extra-pulmonary specimens this fell ... Pulmonary MAC in older individuals is responsible for the majority of this change. We are limited to reporting NTM isolates and ... The incidence of pulmonary MAC increased from 1.3/100,000 to 2.2/100,000 (p < 0.001). The majority of these individuals were ...
The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical ... Recently, the number of patients with CPA complicated by nontuberculous mycobacteria (NTM) has increased. Additionally, ... characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria. ... Patients with chronic pulmonary aspergillosis (CPA) have a poor prognosis and CPA occurs in patients with various underlying ...
Baseline time point was defined as the first positive sputum culture for NTM; symptoms, pulmonary function, and radiology ... Antibiotic therapy against non-tuberculous mycobacteria (NTM) is prolonged and can be associated with toxicity. We sought to ... Glassroth J (2008) Pulmonary disease due to nontuberculous mycobacteria. Chest 133: 243-251. ... Prevots DR, Marras TK (2015) Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest ...
ICS users may be at greater risk for nontuberculous mycobacteria pulmonary disease Patients with obstructive lung disease who ... Nontuberculous mycobacteria are part of a group of bacteria called mycobacteria. The non-tuberculous mycobacteria are, as the ... Researchers develop new method to accurately identify nontuberculous mycobacteria The bacterial genus Mycobacterium has the ... may be at greater risk for nontuberculous mycobacteria pulmonary disease (NTM PD), according to new research presented at the ...
Nontuberculous mycobacteria (NTM) are environmental organisms that colonize or infect lung transplant recipients. Due to ... A Registry for Nontuberculous Mycobacterial Pulmonary Disease. Background: NTM(Nontuberculous mycobacteria) pulmonary disease ... Mycobacterium Infections, Nontuberculous. Infections with nontuberculous mycobacteria (atypical mycobacteria): M. kansasii, M. ... Pulmonary or extrapulmonary infection caused by MYCOBACTERIUM TUBERCULOSIS or nontuberculous mycobacteria in a patient with ...
... pulmonary disease (PD) and NTM pulmonary isolation (PI), from the healthcare payer perspective, we conducted a population-based ... To determine incidence-based healthcare costs attributable to nontuberculous mycobacterial (NTM) ... nontuberculous mycobacteria pulmonary disease; NTM-PI, nontuberculous mycobacteria pulmonary isolation. ... Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001-2012 Lauren C. Ramsay. , Emily Shing, John ...
Pulmonary nontuberculous mycobacteria in men with bronchiectasis",. abstract = "Pulmonary nontuberculous mycobacterial (NTM) ... keywords = "Atypical mycobacteria, Bronchiectasis, Kyphoscoliosis, Nontuberculous mycobacteria, Pectus excavatum, Pulmonary ... Pulmonary nontuberculous mycobacteria in men with bronchiectasis. Together they form a unique fingerprint. * Nontuberculous ... Lady Windermeres counterpart? Pulmonary nontuberculous mycobacteria in men with bronchiectasis. Jennifer H. Ku, Gregory ...
Nontuberculous Mycobacterium, Myobacterium and Mixed Pulmonary Infections: A Case Report Article Sidebar. ... Nontuberculous Mycobacterium, Myobacterium and Mixed Pulmonary Infections: A Case Report. BKK Med J [Internet]. 2015Feb.20 [ ... Nontuberculous mycobacteria in the environment. Clin Chest Med 2002;23:529-51.. 7. Chan ED, Iseman MD. Slender, older women ... 4. Gopinath K, Singh S. Non-tuberculous mycobacteria in TB-endemic countries: are we neglecting the danger?. PLoS Negl Trop Dis ...
Nontuberculous mycobacteria (NTM) are all the other mycobacteria which can cause pulmonary disease resembling tuberculosis, ... Nontuberculous mycobacteria (NTM), also known as environmental mycobacteria, atypical mycobacteria and mycobacteria other than ... pulmonary infections are most commonly due to Mycobacterium avium complex (MAC), Mycobacterium kansasii, and Mycobacterium ... Pulmonary NTM disease diagnosis requires both identification of the mycobacterium in the patients lung(s) as well as a high ...
... may be at greater risk for nontuberculous mycobacteria pulmonary disease (NTM PD), according to new research presented at the ... IMAGE: Study shows inhaled corticosteroids increases risk for nontuberculous mycobacteria pulmonary disease. view more ... may be at greater risk for nontuberculous mycobacteria pulmonary disease (NTM PD), according to new research presented at the ... Session: D94 Non-Tuberculous Mycobacteria: Organism and Host Wednesday, May 18, 2016, 3?3:15 p.m. Location: Room 3020/3022 ( ...
Introduction Non-tuberculous mycobacteria (NTM) are often isolated in patients with chronic obstructive pulmonary disease (COPD ... P83 Non-tuberculous Mycobacteria In Patients With Copd - Frequently Poor Outcomes Despite Treatment ... P83 Non-tuberculous Mycobacteria In Patients With Copd - Frequently Poor Outcomes Despite Treatment ...
HIV/tuberculosis coinfection; Xpert MTB/RIF; nontuberculous mycobacteria; respiratory isolation; tuberculosis diagnosis ... Section of Pulmonary Critical Care and Sleep Medicine, Baylor College of Medicine, Ben Taub General Hospital, Houston, Texas.. ... Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected ... Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected ...
Mycobacterium tuberculosis leads to the onset of tuberculosis in humans. Nontuberculous mycobacteria (NTM) are a species in the ... mycobacteria group that could precipitate illness, but not tuberculosis (TB). ... There are two versions of TB, pulmonary TB (PTB) and extrapulmonary TB (EPTB). PTB is the most often occurring condition. EPTB ... Mycobacterium tuberculosis leads to the onset of tuberculosis in humans. Nontuberculous mycobacteria (NTM) are a species in the ...
IsolatesBacteriaSpeciesDiseaseFortuitumLaboratoryBronchiectasisClinicalLungAbstractComplexIntracellulareRisk for nontuberculous mycobacteria pulmonary diseaseAtypical mycobacteriaSputumOrganismsChronic pulmonaryDiseasesDisease caused by nontuberculous mycobacteria2017Cause severe pulmonaryHumansCOPDInfection causedHypertensionRapidly growing nontuberculous mycoExtrapulmonaryFibrosisIncidence of pulmonaryImmunocompetentPathogenIsolation of nontuberculousLymphadenitisEpidemiologyTreatmentCharacteristicsMycobacterial diseaseUnderlying pulmonary diseaseLeprosySevereAlveolar proteinosisUbiquitousPrevalence of NTM pulmonary diseaseXenopiCritical Care Med2019
- Mycobacterium fortuitum is a nontuberculous species of the phylum actinobacteria (Gram-positive bacteria with high guanine and cytosine content, one of the dominant phyla of all bacteria), belonging to the genus mycobacterium. (wikipedia.org)
- Bacteria classified as Mycobacteria, include the causative agents for tuberculosis and leprosy. (wikipedia.org)
- Mycobacteria are sometimes referred to as "acid-fast bacteria," a term referencing their response to a laboratory staining technique. (wikipedia.org)
- Pulmonary infections of M. fortuitum are uncommon, but Mycobacterium fortuitum can cause local skin disease, osteomyelitis (inflammation of the bone), joint infections and infections of the eye after trauma. (wikipedia.org)
- Different types of sporadic infections: pulmonary disease, local abscesses. (wikipedia.org)
- Pulmonary NTM infection has the highest frequency with male and female patients associated with a higher incidence of COPD and bronchiectasis respectively. (biomedcentral.com)
- Structural pulmonary diseases such as cystic fibrosis, chronic obstructive pulmonary disease (COPD) bronchiectasis, and tuberculosis (TB) predispose individuals to NTM lung infections. (biomedcentral.com)
- Pulmonary disease caused by NTM is most often seen in post-menopausal women and patients with underlying lung disease such as cystic fibrosis, bronchiectasis, and prior tuberculosis. (wikipedia.org)
- Non-tuberculous mycobacteria can cause considerable pulmonary infection in patients with bronchiectasis. (vumc.nl)
- He is a member of the Johns Hopkins Adult Cystic Fibrosis Center, and he co-directs the Johns Hopkins Nontuberculous Mycobacteria and Bronchiectasis Center. (hopkinsmedicine.org)
- Dr. Jennings is an expert in the care of patients with cystic fibrosis, bronchiectasis, NTM pulmonary disease, and the care of critically ill patients in the ICU. (hopkinsmedicine.org)
- He has a master's degree in clinical investigation and is actively engaged in clinical research related to pulmonary infection in patients with cystic fibrosis and bronchiectasis. (hopkinsmedicine.org)
- As the co-founder and co-director of the Johns Hopkins Center for Nontuberculous Mycobacteria and Bronchiectasis, she serves as principal investigator of our Center's cohort study and biobank, and principal investigator for multiple clinical trials pertaining to nontuberculous mycobacterial infections. (hopkinsmedicine.org)
- Dr. Olivier's research focuses on bronchiectasis , a condition that damages the body's ability to clear mucus from the airways and increases risk of severe lung infections by nontuberculous mycobacteria (NTM), which commonly are found in wet environments such as streams, rivers, and marshes. (nih.gov)
- Patients' preexisting conditions such as severe lung infection or past TB, bronchiectasis, emphysema, cystic fibrosis, rheumatoid arthritis and other chronic diseases with pulmonary manifestations can frequently predispose to acquiring a NTM and developing a mycobacterioses (MB). (scielo.org.ar)
- NTM are ubiquitous in the environment and occasionally infect humans with various predisposing conditions like cystic fibrosis, bronchiectasis or immunosuppression, causing a variety of pathological conditions including pulmonary, skin and soft tissue infections and disseminated diseases ( Chan and Iseman, 2013 ). (frontiersin.org)
- Bronchiectasis and non-tuberculous mycobacterial pulmonary infection. (medscape.com)
- Davies G, Wells AU, Doffman S, Watanabe S, Wilson R. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. (medscape.com)
- 1 , 4 , 5 Moreover, delays in diagnosis of bronchiectasis of years to decades commonly occur in children 4 and adults, 6 and it is likely that many remain undiagnosed and untreated, risking premature and accelerated pulmonary decline. (mja.com.au)
- Nevertheless, it has been diagnosed in immunocompetent elderly men, frequently with previous pulmonary disease: chronic obstructive lung disease (COPD), complications of tuberculosis, pulmonary fibrosis and bronchiectasis. (scielo.br)
- In HIV negative patients, MAC has been cultivated from the sputum of patients with previous pulmonary disease, such as bronchiectasis, cystic fibrosis, COPD, and pulmonary fibrosis [1-6. (scielo.br)
- Bronchiectasis can also be related to more common conditions, including chronic obstructive pulmonary disease (COPD) , asthma , or chronic, recurrent aspiration. (merckmanuals.com)
- There are a number of risk factors that can increase a person's chances of acquiring NTM infections, including history of bronchiectasis, chronic obstructive pulmonary disease, smoking, HIV/AIDS, use of immunosuppressive drugs and certain genetic conditions, such as cystic fibrosis and alpha-1 antitrypsin deficiency. (ariva.de)
- It is often difficult to determine if the symptoms are due to mycobacterial infection or the underlying lung disease, such as bronchiectasis, cystic fibrosis, or chronic obstructive pulmonary disease. (oncologynurseadvisor.com)
- Pulmonary disease may show different clinical patterns: tuberculosis like infiltrates, nodular bronchiectasis, solitary nodules, and diffuse infiltrates Footnote 3 , Footnote 6 . (canada.ca)
- The clinical relevance of newly described nontuberculous mycobacteria is often unclear. (cdc.gov)
- This study aimed to delineate epidemiological and clinical features of pulmonary NTM disease. (biomedcentral.com)
- Pulmonary, lymphadenitis, skin/soft tissue and dissemination are the four major clinical manifestations of NTM infections. (biomedcentral.com)
- Although non-tuberculous mycobacteria (NTM) infection is not a reportable disease in the United States, recent data suggest that the prevalence of the disease is increasing in the United States [ 1 , 2 ], mainly due to increased clinical suspicion, improving diagnostic capability, and the aging of the general population [ 3 ]. (clinmedjournals.org)
- We documented a 6-fold increase in the frequency of nontuberculous mycobacteria isolated from clinical samples in Botswana during 2011-2014. (bioportfolio.com)
- Clinical factors on cavitary and nodular bronchiectatc types in pulmonary Myobacterium avium complex disease. (tci-thaijo.org)
- Gugliemetti L, Mougari F, Lopes A, Raskine L, Cambau E. Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view. (springer.com)
- Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series. (springer.com)
- There is growing recognition of the clinical importance of non-tuberculous mycobacteria (NTM), a group of versatile opportunistic bacterial pathogens. (bmj.com)
- We used the 'microbiological' criteria of the American Thoracic Society 2007 NTM guidelines to estimate the clinical significance of pulmonary isolates. (bmj.com)
- The detailed description of this research and its findings will be presented at Session C30 entitled 'Late Breaking Abstracts in Disease Treatment and Clinical Outcomes at 8:15 am-10:45 am on Tuesday, May 20, 2014 (Abstract ID/Title: #57372 - Liposomal Ciprofloxacin Preparation is Active against Mycobacterium Avium Subsp Hominissuis and Mycobacterium Abscessus in Macrophages and in Biofilm) at the American Thoracic Society 2014 International Conference in San Diego, CA. (fiercepharma.com)
- Most patients with positive sputum cultures do not have any clinical or radiographic evidence of pulmonary disease. (armiart.com)
- Nontuberculous mycobacteria in a tertiary Hospital in Portugal: A clinical review. (bioportfolio.com)
- Evaluation of MALDI-TOF MS for identification of nontuberculous mycobacteria isolated from clinical specimens in mycobacteria growth indicator tube medium. (bioportfolio.com)
- Clinical aspects in patients with pulmonary infection caused by mycobacteria of the Mycobacterium abscessus complex, in the Brazilian Amazon. (bioportfolio.com)
- To describe the clinical manifestations of patients with pulmonary infection caused by mycobacteria of the Mycobacterium abscessus complex (MABSC), and to compare these manifestations with those of pa. (bioportfolio.com)
- Background: The clinical significance of nontuberculous mycobacteria (NTM) pulmonary infection in medical intensive care unit (ICU) is still unclear. (elsevier.com)
- Comparison of the Spectrum of Radiologic and Clinical Manifestations of Pulmonary Disease Caused by Mycobacterium avium Complex and Mycobacterium xenopi. (medscape.com)
- To elucidate the clinical features of Aspergillus infections with underlying pulmonary disease, we analyzed 79 cases with positive results for anti-aspergillus antibody. (nih.gov)
- A 30-year-old male patient with acquired immune deficiency syndrome (AIDS) on highly active antiretroviral therapy (HAART) presented with clinical picture suggestive of pulmonary tuberculosis. (hindawi.com)
- Research directed at practical clinical, translational, and fundamental questions is incorporated into the very essence of the Montefiore-Einstein Pulmonary Medicine Division. (montefiore.org)
- Fulltime members of the Pulmonary Medicine Division are actively engaged in basic, translational, and clinical research endeavors, ranging from studies of functional and population genetics and epigenetics, to respiratory and vascular physiology to clinical investigations on pathophysiology and treatment. (montefiore.org)
- Dr. Josanna Rodriguez-Lopez's main clinical research interest is in pulmonary hypertension, and associated clinical trials. (montefiore.org)
- Until such evidence becomes available, it is reasonable for clinicians to follow published clinical practice guidelines for the diagnosis and treatment of nodular or bronchiectatic pulmonary disease due to Mycobacterium avium complex or Mycobacterium abscessus in patients with cystic fibrosis. (cochrane.org)
- The clinical presentations of pulmonary mycobacterium avium complex (MAC) infections in immunocompetent hosts may be classified as those with (a) preexisting lung disease, (b) no preexisting lung disease, and (c) atypical and rare presentations. (hindawi.com)
- AITB ), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, today announced financial results for the fourth quarter and year ended December 31, 2017. (benzinga.com)
- His clinical interests include sarcoidosis, pulmonary alveolar proteinosis, critical care and interstitial lung diseases. (clevelandclinic.org)
- Although NTM infection has traditionally been associated with immunosuppressed individuals or those with severe underlying lung damage, pulmonary NTM infection and disease may occur in people with no overt immune deficiency. (biomedcentral.com)
- It is not clear why this is so, and possible explanations include an increase in the number of individuals with structural lung damage making them more susceptible to mycobacterial infection, more mycobacteria in the environment, improved laboratory detection techniques, a greater awareness of their potential relevance - resulting in more frequent mycobacterial culture being performed, or the result of more investigation to exclude M. tuberculosis . (biomedcentral.com)
- The U.S. Food and Drug Administration today approved a new drug, Arikayce, for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex in a limited population of patients with the disease who do not respond to conventional treatment. (news-medical.net)
- Patients using inhaled steroids to control asthma and other breathing problems may be at greater risk for developing nontuberculous mycobacteria lung infections, according to new research published online in the Annals of the American Thoracic Society. (news-medical.net)
- Patients with obstructive lung disease who take inhaled corticosteroids (ICS) may be at greater risk for nontuberculous mycobacteria pulmonary disease (NTM PD), according to new research presented at the ATS 2016 International Conference. (news-medical.net)
- Nontuberculous mycobacteria in lung transplant recipients: Prevalence, risk factors and impact on survival and chronic lung allograft dysfunction. (bioportfolio.com)
- Nontuberculous mycobacteria (NTM) are environmental organisms that colonize or infect lung transplant recipients. (bioportfolio.com)
- A prospective, single-center, open-label study involving patients with refractory nontuberculous mycobacteria lung disease to ascertain pharmacokinetics, safety, efficacy, and tolerability. (bioportfolio.com)
- 7. Chan ED, Iseman MD. Slender, older women appear to be more susceptible to nontuberculous mycobacterial lung disease. (tci-thaijo.org)
- Our objective was to determine if ICS use is associated with an increased risk of nontuberculous mycobacterial pulmonary disease (NTM PD) in persons with obstructive lung disease (OLD). (eurekalert.org)
- NTM-based disease of the lung describes a family of disorders in which individuals come in contact with mycobacteria. (news-medical.net)
- The bacteria can infect the pulmonary system, including the lung. (news-medical.net)
- Pulmonary disease with MAC has long been recognized in patients with chronic lung disease or certain hematologic malignancies. (armiart.com)
- Patients traditionally described are middle-aged men with underlying chronic lung disease, such as chronic obstructive pulmonary disease, who have upper lobe cavity formation and nodules of various sizes. (cdc.gov)
- In conclusion, severe nontuberculous mycobacterial lung disease, particularly with Mycobacterium abscessus , is becoming a perplexing challenge in cystic fibrosis patients. (ersjournals.com)
- Pulmonary disease was evaluated by lung function, chest radiograph, and sputum culture for bacteria and fungi, as well as mycobacteria. (ersjournals.com)
- Diagnosis of Nontuberculous Mycobacteria Lung Disease. (bioportfolio.com)
- Pulmonary infections are particularly common and serious in the susceptible population of lung transplant recipients. (redorbit.com)
- Study Finds Nontuberculous Mycobacteria Lung Disease on the Rise in the U.S. (infectioncontroltoday.com)
- Reference: Hospitalizations for nontuberculous mycobacteria-associated lung disease, United States, 1998-2005. (infectioncontroltoday.com)
- Pulmonary nontuberculous mycobacteria (NTM) disease is a chronic and debilitating lung disease caused by ubiquitous environmental bacteria, found in soil as well as natural and engineered water systems. (biomedreports.com)
- At ERS, the Company will present updated data from its NO-BRO pilot study in infants hospitalized with acute bronchiolitis, as well as data highlighting the potential use of NO as a treatment option for Mycobacterium abscessus complex (MABSC) of the lung. (globenewswire.com)
- Intensive treatment seeks to improve symptom control, reduce frequency of acute pulmonary exacerbations, preserve lung function, and maintain a good quality of life. (mja.com.au)
- The main purpose of this review was to determine whether treatment with different antibiotic combinations for nontuberculous mycobacterial infection would improve lung function or decrease the frequency of chest infections in people with cystic fibrosis. (cochrane.org)
- The main aim of this review was to show whether or not treating nontuberculous mycobacterial infection with different combinations of antibiotics improves lung function or decreases the frequency of chest infections in people with cystic fibrosis. (cochrane.org)
- This review did not find any evidence for the effectiveness of different antimicrobial treatment for nontuberculous mycobacteria lung disease in people with cystic fibrosis. (cochrane.org)
- Although there are guidelines for the antimicrobial treatment of nontuberculous mycobacteria lung disease, these recommendations are not specific for people with cystic fibrosis and it is not clear which antibiotic regimen may be the most effective in the treatment of these individuals. (cochrane.org)
- The objective of our review was to compare antibiotic treatment to no antibiotic treatment, or to compare different combinations of antibiotic treatment, for nontuberculous mycobacteria lung infections in people with cystic fibrosis. (cochrane.org)
- The overarching mission of the Honda Lab is to understand the biology of nontuberculous mycobacterial (NTM) lung disease. (nationaljewish.org)
- Describes a case of lung infection due to Mycobacterium simiae in an immunocompromised patient without AIDS. (ebscohost.com)
- is the most pathogenic and most likely to produce pulmonary disease, causing approximately 80% of lung disease due to RGM. (oncologynurseadvisor.com)
- On October 23, 2017, the last patient completed treatment in our Phase 2 NO-NTM abscessus trial for the treatment of Nontuberculous Mycobacteria (NTM) abscessus lung disease. (globenewswire.com)
- We demonstrate that whilst there has been a significant increase in a number of NTM, the overall rise is largely explained by pulmonary Mycobacterium avium-intracellulare complex. (biomedcentral.com)
- Mycobacteria are a family of small, rod-shaped bacilli that can be classified into 3 main groups for the purpose of diagnosis and treatment: Mycobacterium tuberculosis complex which can cause tuberculosis: M. tuberculosis, M. bovis, M. africanum, M. microti and M. canetti. (wikipedia.org)
- They have been classified as nontuberculosis to differentiate them from tuberculosis-causing bacteria, also known as the Mycobacterium tuberculosis ( M.tb ) complex. (news-medical.net)
- The Mycobacterium avium complex (MAC) is NTM. (news-medical.net)
- The Mycobacterium tuberculosis complex is the cause of TB. (news-medical.net)
- Isolated SGM strains were Mycobacterium avium complex (MAC) in 25/85 (29.41%) patients, M. xenopi in 20/85 (23.53%) patients, M. kansasii in 15/85 (17.65%) patients and M. peregrinum and M. gordonae in 5/85 (5.88%) patients each. (springer.com)
- In both the man and the woman, non-tuberculous mycobacteria were identified (Mycobacterium avium complex and Mycobacterium abscessus, respectively). (vumc.nl)
- This study will test the safety and effectiveness of inhaled interferon gamma-1b and oral antibiotics for treating mycobacterium avium complex (MAC) infection of the lungs. (clinicaltrials.gov)
- Nontuberculous mycobacterial infections due to Mycobacterium avium complex (MAC) are a growing problem among older Americans, especially women. (clinicaltrials.gov)
- In opposition to Mycobacterium tuberculosis complex members, non-tuberculous mycobacteria (NTM) are free-living and ubiquitously distributed microorganisms with diverse ability to cause disease in humans. (scielo.org.ar)
- Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. (medscape.com)
- RDHL ) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for a pivotal Phase 3 study to evaluate the efficacy and safety of RHB-204 in adults with pulmonary nontuberculous mycobacteria (NTM) disease caused by Mycobacterium avium Complex (MAC) infection. (biomedreports.com)
- Pulmonary manifestations account for 80-90% of all NTM-associated diseases 5 , and approximately 80% of pulmonary NTM infections are caused by Mycobacterium avium Complex (MAC) 6 . (biomedreports.com)
- RHB-204 is a proprietary, fixed-dose oral capsule containing a combination of clarithromycin, rifabutin, and clofazimine, developed for the treatment of pulmonary NTM infections caused by Mycobacterium avium Complex (MAC). (biomedreports.com)
- Nontuberculous mycobacteria are mycobacteria, other than those in the Mycobacterium tuberculosis complex, and are commonly found in the environment. (cochrane.org)
- Mycobacterium avium complex (MAC) infections rarely affect the pleura, accounting for 5-15% of pulmonary MAC. (hindawi.com)
- Six weeks later, mycobacterium avium complex was isolated from pleural fluid and pleural biopsy specimens, by DNA hybridization. (hindawi.com)
- Nontuberculous Mycobacteria (NTM), especially Mycobacterium avium -intracellulare complex (MAC), has been considered responsible for human disease, especially in HIV patients. (scielo.br)
- M. avium complex or M. avium-intracellulare disseminated infection may occur in AIDS and cause cervical adenitis in children and pulmonary disease in immunodeficient patients. (thefreedictionary.com)
- The great majority (96%) of disease due to atypical mycobacteria is caused by Mycobacterium avium complex (MAC). (ebscohost.com)
- Subjects with either M. abscessus or Mycobacterium avium complex (MAC) infection will be enrolled, with all subjects having either antibiotic refractory infection or intolerance to standard NTM antibiotics. (benzinga.com)
- Announced publication of data showing significant improvement in bacterial load in two cystic fibrosis patients with Mycobacterium abscessus complex (MABSC) in a compassionate use trial, while also showing the treatment was safe and tolerable. (globenewswire.com)
- It includes more than one bacterium - Mycobacterium avium and Mycobacterium intracellulare . (news-medical.net)
- This entry was posted in Respiratory Symptoms and tagged AIDS , atypical Mycobacterium infections , HIV infection , Mycobacterium avium-intracellulare infection . (armiart.com)
- However, the organisms are ubiquitous in the environment, and substantial evidence shows that the environmental niche for Mycobacterium intracellulare (the most common pulmonary pathogen) is in biofilms lining suburban water pipes. (cdc.gov)
- Mycobacterium avium and Mycobacterium intracellulare as the main causative agents. (scielo.org.ar)
- In Japan, the causative NTM strain for pulmonary disease with the highest incidence is M. avium (approximately 60%), followed by M. intracellulare , M. kansasii , and M. abscessus , and the incidence per 100,000 population increased remarkably from 5.7 in 2007 to 14.7 in 2014 ( 9 , 11 ). (asm.org)
- Presents a case report of a child with a stiff neck, who was eventually diagnosed to have osteomyelitis due to mycobacterium avium intracellulare. (ebscohost.com)
- Study shows inhaled corticosteroids increases risk for nontuberculous mycobacteria pulmonary disease. (eurekalert.org)
- Nontuberculous mycobacteria (NTM), also known as environmental mycobacteria, atypical mycobacteria and mycobacteria other than tuberculosis (MOTT), are mycobacteria which do not cause tuberculosis or leprosy (also known as Hansen's disease). (wikipedia.org)
- anonymous mycobacteria , atypical mycobacteria nontuberculous mycobacteria . (thefreedictionary.com)
- Atypical mycobacteria, non-tuberculous mycobacteria ( NTM ), mycobacteria other than tubercle bacilli ( MOTT ) Footnote 1 - Footnote 3 . (canada.ca)
- Xpert was compared to 2 sputum samples, each evaluated with acid-fast bacilli (AFB) smear and mycobacterial culture using liquid and solid culture media, from participants with suspected pulmonary tuberculosis from the United States, Brazil, and South Africa. (nih.gov)
- Non-tuberculous mycobacteria in the sputum of HIV-infected patients: infection or colonization? (medscape.com)
- Of the 3102 participants in the active surveillance group, four subjects were diagnosed with definite tuberculosis, four subjects with probable tuberculosis, and 71 subjects had non-tuberculous Mycobacteria (NTM) isolated from their sputum. (biomedcentral.com)
- On admission his chest X-ray showed multiple well defined cavitary lesions seen within the right upper lobe and his sputum was positive for acid fast bacilli resembling Mycobacterium tuberculosis . (hindawi.com)
- Secondary endpoints include a 6-minute walk test and Mycobacterium abscessus load in sputum. (globenewswire.com)
- Non-tuberculous mycobacteria (NTM) are ubiquitous organisms associated with various infections. (springer.com)
- The most common organisms were slow-growing mycobacteria (SGM) presented in 70/85 (82.35%) patients. (springer.com)
- Mycobacterium lentiflavum organisms are nontuberculous mycobacteria (NTM) first identified in 1996 ( 1 ). (cdc.gov)
- Their illnesses were caused by organisms that were not Mycobacterium tuberculosis . (medscape.com)
- Nontuberculous mycobacteria (NTM) are environmental organisms found in both water and soil that can cause severe pulmonary disease in humans. (infectioncontroltoday.com)
- Nontuberculous mycobacteria (NTM) are naturally-occurring organisms found in water and soil. (lung.org)
- Nontuberculous mycobacteria are ubiquitous organisms commonly isolated from the environment and identified in drinking water and soil. (ariva.de)
- Ex: M. tuberculosis, M. avium-intra-cellulare, M. bovis, M. ulcerans Ex: M. fortuitum, M. chelonae Mycobacteria are classical acid-fast organisms. (wikipedia.org)
- Mycobacteria are widespread organisms, typically living in water (including tap water treated with chlorine) and food sources. (wikipedia.org)
- Non-tuberculous mycobacteria (NTM) are emerging worldwide as significant causes of chronic pulmonary infection, posing a number of challenges for both clinicians and researchers. (nih.gov)
- Patients with chronic pulmonary aspergillosis (CPA) have a poor prognosis and CPA occurs in patients with various underlying diseases. (ovid.com)
- Chronic pulmonary disease (CLD) is the most common manifestation of HIV/AIDS among children, accounting for more than 50% of HIV-associated mortality. (nih.gov)
- M. intracellula´re occasionally causes chronic pulmonary disease in adults and lymph node infection in children. (thefreedictionary.com)
- Pulmonary cases (352, 76%) had the highest prevalence among patients diagnosed with NTM diseases (465/852, 54.6%) with no gender difference. (biomedcentral.com)
- NTM do cause pulmonary diseases that resemble tuberculosis. (wikipedia.org)
- An official ATS/IDSA statement: diagnosis, treatment and prevention of nontuberculous mycobacterial diseases. (springer.com)
- People with severe pulmonary diseases including cystic fibrosis, chronic obstructive pulmonary disease (COPD), and Alpha-1 Antitrypsin deficiency are particularly vulnerable to pulmonary non-tuberculous mycobacteria (PNTM) infections. (fiercepharma.com)
- The presence of coronary lesions on coronary CT was significantly correlated with pulmonary emphysema but not with other pulmonary diseases. (ersjournals.com)
- The most common diseases caused by NTM are lymphadenitis in children and pulmonary diseases in adults. (iwaponline.com)
- Records were extracted for all persons with a pulmonary NTM International Classification of Diseases code (031.0) hospitalized in the 11 states with continuous data available from 1998 through 2005. (medscape.com)
- This becomes most obvious in the subgroup of immunosuppressed patients who are at risk of severe courses of diseases with higher morbidity and mortality from infections with viruses and facultative pathogens, such as nontuberculous mycobacteria (NTM). (springer.com)
- Other diseases that have been caused by Mycobacterium. (ebscohost.com)
- This revision has been made primarily to update the information on tuberculin skin testing and laboratory services for the diagnosis of tuberculosis, and to remove material pertaining to nontuberculous mycobacterial diseases, which will henceforth be dealt with separately. (cdc.gov)
- This genus includes pathogens known to cause serious diseases in mammals, including tuberculosis (Mycobacterium tuberculosis) and leprosy (Mycobacterium leprae) in humans. (wikipedia.org)
- The incidence of non-tuberculous mycobacteria (NTM) isolation from humans is increasing worldwide. (biomedcentral.com)
- Mycobacterium tuberculosis leads to the onset of tuberculosis in humans. (news-medical.net)
- Nontuberculous mycobacteria (NTM) are ubiquitous in the environment, including natural water, soil, and household dust ( 1 , 2 ), and can cause significant disease in humans and animals ( 3 ). (asm.org)
- M. a´vium causes tuberculosis in birds and pigs and pulmonary disease in humans. (thefreedictionary.com)
- Rationale: Inhaled corticosteroids (ICS) are widely used to treat asthma and chronic obstructive pulmonary disease (COPD). (eurekalert.org)
- Introduction Non-tuberculous mycobacteria (NTM) are often isolated in patients with chronic obstructive pulmonary disease (COPD). (bmj.com)
- Infection with M xenopi may result in pulmonary infection, usually in older adults with COPD, in patients who are immunocompromised with disseminated disease, or in patients with extrapulmonary disease involving the lymphatic system, skin, bones, or joints. (medscape.com)
- We report a case of pulmonary infection caused by Mycobacterium hassiacum in an immunocompetent patient in Austria who had chronic obstructive pulmonary disease. (cdc.gov)
- Pulmonary or extrapulmonary infection caused by MYCOBACTERIUM TUBERCULOSIS or nontuberculous mycobacteria in a patient with silicosis. (bioportfolio.com)
- She is, along with Dr. Ronald Zolty (Cardiology), assembling a Montefiore multi-disciplinary Pulmonary Hypertension Center. (montefiore.org)
- Certain vasodilator therapies are used in patients who have pulmonary hypertension related to their sarcoidosis, but these therapies are not used for sarcoidosis itself. (clevelandclinic.org)
- In vitro activity of bedaquiline against rapidly growing nontuberculous mycobacteria. (cambridge.org)
- Are you sure your patient has disease due to rapidly growing nontuberculous mycobacteria? (oncologynurseadvisor.com)
- How did the patient develop disease due to rapidly growing nontuberculous mycobacteria? (oncologynurseadvisor.com)
- Which individuals are of greater risk of developing disease due to rapidly growing nontuberculous mycobacteria? (oncologynurseadvisor.com)
- There are two versions of TB, pulmonary TB (PTB) and extrapulmonary TB (EPTB). (news-medical.net)
- The American Thoracic Society/Infectious Disease Society of America criteria were used to define cases of pulmonary or an extrapulmonary site. (springer.com)
- Pulmonary cases predominated 83/85 (98%), while extrapulmonary NTM were present in 2/95 (2%) patients. (springer.com)
- In the present study, pulmonary NTM infections were more frequent compared to extrapulmonary disease forms. (springer.com)
- We conducted a case-control study of 34 men with non-cystic fibrosis pulmonary NTM disease (cases), and three male and female control groups with or without NTM disease. (elsevier.com)
- Those at greater risk also may have pulmonary tissue that has been damaged from such illnesses as emphysema, cystic fibrosis, or even previous TB. (news-medical.net)
- Nontuberculous mycobacterial (NTM) infection, particularly due to Mycobacterium abscessus , is an emerging disease that can be relentlessly progressive, particularly in cystic fibrosis (CF) patients. (ersjournals.com)
- Between 1997 and 2002, the charts of 139 Israeli CF patients, followed at the Graub Cystic Fibrosis Center and Pulmonary Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel, and the Cystic Fibrosis Center, Carmel Medical Center Haifa, Israel, were reviewed. (ersjournals.com)
- We reviewed the evidence about using antibiotics to treat nontuberculous mycobacteria infection in people with cystic fibrosis. (cochrane.org)
- However, person-to-person transmission has recently been reported among cystic fibrosis patients infected with Mycobacterium abscessus ( 6 ). (asm.org)
- Early life growth patterns persist for 12 years and impact pulmonary outcomes in cystic fibrosis. (ecfs.eu)
- The activity of 20S proteasome in bronchoalveolar labage fluid tend to be higher in the patients with idiopathic pulmonary fibrosis (IPF) than normal subjects or sarcoidosis patients. (nii.ac.jp)
- He has a secondary appointment as an associate staff scientist in the Lerner Research Institute Department of Pathobiology, where his research focus is idiopathic pulmonary fibrosis (IPF). (clevelandclinic.org)
- In Korea, the incidence of pulmonary NTM disease has doubled in 2015 compared to the number in 2009 [ 23 , 24 ]. (biomedcentral.com)
- The objective of current study is to estimate the incidence of pulmonary tuberculosis (PTB) disease among adolescents attending school in South India using two different surveillance methods (active and passive) and to compare the incidence between the two groups. (biomedcentral.com)
- The incidence of pulmonary tuberculosis among adolescents in our study is lower than similar studies conducted in South Africa and Eastern Uganda - countries with a higher incidence of tuberculosis and human immunodeficiency virus (HIV) than India. (biomedcentral.com)
- hominissuis mainly causes disseminated infection in immunocompromised hosts, such as individuals with human immunodeficiency virus (HIV) infection, and pulmonary infection in immunocompetent hosts. (asm.org)
- It is necessary to identify the type of mycobacteria in immunocompetent individuals with positive AFB smears that do not become negative with tuberculosis treatment. (scielo.br)
- Pulmonary Infection Due to Mycobacterium marinum in an Immunocompetent Patient. (ebscohost.com)
- Presents a letter to the editor that focuses on pulmonary infection due to mycobacterium marinum in an immunocompetent patient. (ebscohost.com)
- Mycobacterium triplex Pulmonary Disease in Immunocompetent Host. (ebscohost.com)
- Non-tuberculous mycobacteria ( NTM ) infections occur mainly in immunosuppressed individuals, although immunocompetent patients can also be affected Footnote 4 , Footnote 6 . (canada.ca)
- In countries to which tuberculosis (TB) is endemic, the tuberculosis was isolated from 5,878 (43.1%) patients and isolation of nontuberculous mycobacteria (NTM) from NTM from 7,774 (56.9%) patients. (cdc.gov)
- Epidemiologic Review of Veterans Health Administration Patients with Isolation of Nontuberculous Mycobacteria after Cardiopulmonary Bypass Procedures. (cambridge.org)
- Nontuberculous mycobacteria (NTM) are all the other mycobacteria which can cause pulmonary disease resembling tuberculosis, lymphadenitis, skin disease, or disseminated disease. (wikipedia.org)
- Infection is acquired from environmental reservoirs and usually manifests as pulmonary disease, although lymphadenitis, soft tissue infection and bacteraemia may also result. (bmj.com)
- NTM infections can occur throughout the body, although pulmonary infections, lymphadenitis, and skin and soft tissue infections are the most commonly affected areas. (ariva.de)
- The epidemiology of NTM pulmonary disease differs in various geographical regions. (biomedcentral.com)
- Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. (springer.com)
- Identify the prevalence and epidemiology of nontuberculous mycobacteria (NTM) infection and traditional risk factors and presentation of pulmonary NTM infection. (cdc.gov)
- This study should clarify the therapeutic role for aerosolized interferon gamma in the treatment of nontuberculous mycobacterial infections. (clinicaltrials.gov)
- Twenty-one (49%) patients with NTM pulmonary infection received anti-NTM treatment, with four experiencing adverse effects. (elsevier.com)
- Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis. (medscape.com)
- Nontuberculous mycobacteria isolated during the treatment of pulmonary tuberculosis. (medscape.com)
- Pulmonary infections in transplant recipients present a diagnostic challenge and are a continuing source of mortality and morbidity despite improvement in prophylaxis and treatment. (redorbit.com)
- Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense. (nationaljewish.org)
- Our study describes the prevalence, demographic characteristics, and trends of pulmonary NTM-associated hospitalizations during 1998-2005. (medscape.com)
- We report a case of pulmonary infection due to this mycobacterium in an immuno-competent patient and review the characteristics of two other cases. (ebscohost.com)
- He had a medical history of chronic obstructive pulmonary disease with severe emphysema because of cigarette smoking. (cdc.gov)
- Recently, the current authors have encountered CF patients with severe unexplained pulmonary deterioration, which proved to be related to NTM infection, particularly that due to M. abscessus . (ersjournals.com)
- Other findings include: diffuse or severe warts, including perineal and cervical, pulmonary alveolar proteinosis, and clubbing. (clinicaladvisor.com)
- Having successfully pioneered inhaled GM-CSF for over a decade in patients with pulmonary alveolar proteinosis (PAP), we were prompted to try the same approach to treat NTM infection after learning of the increasing scientific evidence of GM-CSF's important role in activating macrophages to kill mycobacteria. (benzinga.com)
- Pulmonary alveolar proteinosis is eventually seen in up to 50% of patients. (clinicaladvisor.com)
- The pulmonary alveolar proteinosis resolves with transplantation. (clinicaladvisor.com)
- Mycobacterium malmoense, Mycobacterium xenopi) are regionally important. (nih.gov)
- Discitis and sacroiliitis diagnosed 15years after iatrogenic Mycobacterium xenopi inoculation. (medscape.com)
- Portillo ME, Sánchez F, Vicente E, Salvadó M. [Trochanteric bursitis due to Mycobacterium xenopi in a patient with pharmacological immunosuppression]. (medscape.com)
- Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France. (medscape.com)
- Dr. Jennings is a specialist in Pulmonary and Critical Care Medicine. (hopkinsmedicine.org)
- Dr. Cohen is a specialist in Pulmonary and Critical care Medicine. (hopkinsmedicine.org)
- He completed his internship and residency in internal medicine at the United States Air Force Keesler Medical Center in Biloxi, MS, and a fellowship in pulmonary and critical care medicine at the University of North Carolina at Chapel Hill. (nih.gov)
- Daniel Culver, DO , is a staff physician in the Department of Pulmonary, Allergy and Critical Care Medicine at Cleveland Clinic's Main Campus. (clevelandclinic.org)